APPLICATION
ANDA065072
TYPE
ANDA
ORIGINAL APPROVAL
2002-11-20
LATEST ACTION
2020-06-04
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CEFOTAXIMEDiscontinued
CEFOTAXIME SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
CEFOTAXIMEDiscontinued
CEFOTAXIME SODIUM EQ 2GM BASE/VIAL · INJECTABLE · INJECTION
CEFOTAXIMEDiscontinued
CEFOTAXIME SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-06-04Labeling · Supplement 14 · standardAP
2020-06-04Labeling · Supplement 12 · standardAP
2012-08-03Labeling · Supplement 11AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.